Catherine Bollard, MD, professor of pediatrics and of microbiology, immunology, and tropical medicine, spoke to WTOP for an article about a new FDA-approved gene modification process that shows promise in cancer treatment.
WTOP - ‘Highly Revolutionary’: Newly FDA-Approved Gene Modification Has Promise in Cancer Treatment
Latest News
GW SMHS MD Program Class of 2025 gathered in Lisner Auditorium, where their medical school journeys first started four years earlier, to lear where they will go for residency training at the annual National Residency Matching Program Match Day, March 21.
A basket clinical trial focused on a pair of rare mitochondrial diseases, MELAS and LHON-Plus, is led by Anne Chiaramello, PhD, professor of anatomy and cell biology at GW SMHS, is now registration on ClinicalTrials.gov.
Firefighters from D.C. and Northern Virginia complete rigorous training to meet growing demand for advanced life-saving care.